GLP-1 drug for psoriatic arthritis in overweight patients without diabetes
Treatments studied
Part of Bones, joints & muscles, Hormones & metabolism, Skin clinical trials.
This trial tests if a GLP-1 receptor agonist (a type of diabetes medication) can help treat psoriatic arthritis in people who are overweight but do not have diabetes. You might join if you have psoriatic arthritis, a high BMI, and you are of Chinese descent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have psoriatic arthritis as diagnosed by a doctor
- You are 18 or older and of Chinese descent
- Your BMI is 25 or higher (overweight or obese)
- You have not taken any GLP-1 medications in the past 6 months
- You do not have diabetes, heart disease, pancreatitis, cancer, or liver/kidney problems
- You are not pregnant, breastfeeding, or planning to become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if semaglutide, a medicine used for diabetes and weight loss, can help people with both psoriasis and obesity. You may qualify if you have moderate to severe psoriasis, a high body weight, and are of Chinese descent.
This trial tests if semaglutide, a diabetes and weight-loss medication, can improve psoriasis symptoms and reduce inflammation. It may be an option for people with both psoriasis and overweight or obesity, with or without diabetes.
This study tests if adding a GLP-1 medication (a type of drug that helps with weight and blood sugar) to your usual psoriatic arthritis treatment can improve your joint and skin symptoms. It is for people with psoriatic arthritis who have not yet achieved good control of their disease and have a higher body weight.
This trial tests whether semaglutide (a medicine that helps control blood sugar and weight) can improve outcomes for people with type 1 diabetes who have a higher body weight. It may help if you have had type 1 diabetes for at least 3 years and have a BMI of 30 or more, or 27 or more with a related health problem.
This trial tests if a GLP-1 receptor agonist (a type of diabetes drug that helps with weight loss) can help men with prostate cancer who are on hormone therapy (ADT) and have a high body mass index (BMI). It aims to see if it improves their health and outcomes.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
Hear when a new Psoriasis Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.